Validation of the Performance of the French Version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a Screening Test for Cerebellar Cognitive-affective Syndrome: a National Multicenter Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGroupe Hospitalier de la Region de Mulhouse et Sud Alsace

About this trial

The primary objective of the study is to assess the performance of the French version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a screening test for cerebellar cognitive-affective syndrome.

The primary endpoint will be the sensitivity of version 1A of the French scale. The result will be considered positive if the patient fails at least one of the scale's subtests. The diagnosis of a cerebellar cognitive-affective syndrome will be made on the basis of a pathological score in the executive, language, visuospatial or psychoaffective domains of the neuropsychological evaluation (gold standard).

Eligibility criteria

Qualifiers

French speaking

Acquired lesion or predominantly degenerative cerebellar pathology of any etiology

Affiliated or beneficiary of a social security scheme

Written informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Cerebellar Cognitive-Affective Syndrome Scale

Treatment groups

217 Participants
are divided into 1 treatment group